Harrow
HaMy Vo, PharmD has extensive experience in the pharmaceutical field, holding positions such as Field Reimbursement Manager and Prior Authorization Review Pharmacist. Vo also served as a Pharmacist in Charge at a pharmacy and as an Executive Pharmacist for the Tampa Bay Buccaneers NFL Team. Vo has a Doctor of Pharmacy degree from Florida Agricultural and Mechanical University.
This person is not in any offices
Harrow
2 followers
Harrow (Nasdaq: HROW) is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten FDA-approved ophthalmic pharmaceutical products. Harrow also owns and operates ImprimisRx, the leading U.S. ophthalmic‑focused pharmaceutical compounding business, which also serves as a mail-order pharmacy licensed to ship prescription medications in all 50 states. Harrow has non-controlling equity positions in Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc., companies that began as subsidiaries of Harrow. Harrow also owns royalty rights in four late-stage drug candidates being developed by Surface and Melt.